Gateway Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Gateway Wealth Partners's BMY Position: Q2 2026 in Review
Gateway Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 48% in Q2 2026, selling an estimated $245K and leaving 4,713 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #662.
Gateway Wealth Partners first reported a position in BMY in Q2 2023 and has held it in 6 quarters since. The position peaked at $545K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Gateway Wealth Partners held 4,713 shares of Bristol-Myers Squibb worth $272K as of Q2 2026.
- Gateway Wealth Partners sold 4,273 Bristol-Myers Squibb shares in Q2 2026, an estimated $245K.
- Bristol-Myers Squibb made up 0.02% of Gateway Wealth Partners's portfolio in Q2 2026, its #662 holding.
- Gateway Wealth Partners first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 6 quarters since.
- Gateway Wealth Partners's Bristol-Myers Squibb position peaked at $545K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.